Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature.

Clinical guidelines

Guidelines for preventive activities in general practice 9th edition

9.7 Testicular cancer

Age 0-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-79 >80
Not recommended as a preventive activity

There is insufficient evidence to routinely screen for testicular cancer using clinical or self-examination.105,106 Those performing testicular self-examination are not more likely to detect early-stage tumours or have better survival than those who do not (C).

Table 9.7.1. Testicular cancer: Identifying risk
Who is at risk?What should be done?How often?
High risk
Those with a history of cryptorchidism (relative risk [RR] = 3.5–17 above average), orchidopexy, testicular atrophy, or previous testicular cancer (RR = 25–28) 106–108 Testicular examination (Practice Point) Opportunistically (Practice Point)
RR, relative risk

References

  1. Elford RW. Screening for testicular cancer. Canadian Task Force on the Periodic Health Examination Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994; p. 892–98.
  2. US Preventive Services Task Force. Screening for testicular cancer: Recommendation statement. Rockville, MD: Agency for Healthcare Research and Quality, 2011.
  3. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22(1):2–14.
  4. National Cancer Institute. Testicular cancer screening. Bethesda, Maryland: US National Institutes of Health, 2012. Available at www.cancer.gov/cancertopics/pdq/screening/testicular/Patient/page3 [Accessed 15 October 2015].
Advertisement loading...

Advertisement